Purpose. Clostridium difficile is an anaerobic spore-forming pathogen that causes a serious toxin-mediated enteric disease in humans. Therapeutic agents that are capable of reducing C. difficile spore production could significantly minimize the transmission and relapse of C. difficile infections. This study investigated the efficacy of a food-grade, plant-derived compound, carvacrol (CR), in reducing C. difficile spore production, germination and spore outgrowth.
INTRODUCTION
Clostridium difficile is a spore-forming anaerobic bacterium that causes a toxin-mediated enteric disease in humans [1] . C. difficile predominantly affects long-term hospital inpatients and the elderly undergoing prolonged antibiotic therapy [2] . Recent epidemiological data have shown that C. difficile has surpassed methicillin-resistant Staphylococcus aureus as the most commonly acquired hospital infection [3] . Prolonged antibiotic therapy results in the disruption of the normal enteric microflora, causing C. difficile spore germination and pathogen colonization in the intestine, with subsequent production of toxins [4] . Although toxins are the major virulence factors responsible for the pathogenesis of C. difficile infection, spore formation, germination and spore outgrowth in C. difficile are critical components of C. difficile infection (CDI) transmission and relapse [5] . Sporulation is a critical virulence factor in C. difficile pathogenesis. C. difficile spores, being survival structures that can withstand unfavourable physical, chemical and metabolic conditions, play an important role in bacterial persistence in the environment, transmission to new susceptible individuals and relapse in temporarily recovered patients [6] . This leads to germination, proliferation and colonization of C. difficile in the gut following prolonged antibiotic treatment that disrupts the normal gut flora, which in turn causes new infections or relapse of CDI [7, 8] . Relapse of CDI is reported in 25 % of patients undergoing anti-C. difficile therapy [9] . Spore production in C. difficile is regulated by several genes, including spo0A, which is the master regulator of Spo0A, together with associated kinases and different sigma factors, such as sigH [10] [11] [12] . Highly resistant C. difficile spores shed in the faeces contaminate hospitals and healthcare facilities, which can cause infection though the faecal-oral route, reinfection or recurrence of CDI in patients following germination, and spore outgrowth [2, 13] . Therefore, agents reducing C. difficile sporulation and spore outgrowth in the human gastrointestinal tract could effectively control C. difficile infection, transmission and relapse [14, 15] .
Despite the fact that exposure to broad-spectrum antibiotics predisposes patients to CDI by disrupting the normal gut flora [16, 17] , antibiotics still constitute the chief treatment strategy against C. difficile. In addition, the emergence of antibiotic resistance in hypervirulent strains of C. difficile is documented [18, 19] . Therefore, alternative therapeutic agents that can attenuate C. difficile virulence without disrupting the normal gut flora represent a viable control approach against the pathogen. Carvacrol (CR) is a monoterpenoid phenol present in oregano and thyme oils. Various pharmacological effects of CR, including antimicrobial and anti-inflammatory properties, have been demonstrated [20] . Our previous study indicated that CR effectively inhibited C. difficile toxin production in vitro, without deleteriously affecting the major normal gastrointestinal flora in humans [21] .
The objective of this study was to investigate the potential of CR to inhibit spore production, spore germination and spore outgrowth in vitro, which are critical in the spread and relapse of C. difficile infection, and to delineate the potential mechanism(s) behind its effect.
METHODS
Bacterial strains and culture conditions Two hypervirulent C. difficile isolates (ATCC BAA 1805, and 1870) were grown in brain heart infusion broth (BHI) supplemented with 5 % yeast extract (Difco, Sparks, MD, USA) in a Whitley A35 anaerobic work station (Microbiology International, Frederick, MD, USA) in the presence of 80 % N 2 , 10 % CO 2 , and 10 % H 2 at 37 C for 24 h. The bacterial population was determined by plating 0.1 ml portions of appropriate dilutions on BHI agar and Clostridium difficile moxalactam norfloxacin (CDMN) agar (Oxoid, Lenexa, KS, USA) supplemented with 5 % horse blood, under strict anaerobic conditions at 37 C for 24 h. The cultures were sedimented by centrifugation (3600 g, 15 min, 4 C), and the pellet was washed twice and resuspended in sterile PBS (pH 7.3), and then used as the inoculum.
C. difficile spore preparation Clostridium difficile spores were prepared as previously described, with slight modifications [22] . Briefly, single colonies of ATCC BAA 1870 and 1805 were separately inoculated into BHIS broth (BHI plus cysteine) and cultured overnight at 37 C under anaerobic conditions. A 150 µl aliquot of overnight culture was spread onto BHI agar (Oxoid) in six-well plates and cultured anaerobically for 10 days at 37 C in a Whitley A35 anaerobic workstation (Don Whitley Scientific, Shipley, West Yorkshire, UK) to allow sporulation. After 10 days, spores were harvested from the wells by flooding with 2 ml ice-cold sterile water. The spore suspension was heat-treated at 60 C for 20 min to kill any vegetative cells, and washed six times in distilled water by centrifuging at 16 000 g for 5 min. Spore suspensions were examined for purity by phase-contrast microscopy before storage at À20 C prior to use.
Carvacrol and determination of SIC and MIC on C. difficile
The sub-inhibitory concentration (SIC) of CR (!98 % purity, Sigma Aldrich, St Louis, MO, USA) against C. difficile was determined, as previously described [23] . Approximately 5.0 log c.f.u. C. difficile (ATCC BAA 1870 and 1805) was inoculated separately in tissue-culture plates containing 2 ml of BHI, followed by the addition of 1 to 10 µl of CR with an increment of 0.5 µl. The plates were then incubated in an anaerobic chamber incubator at 37 C for 24 h with 80 % N 2 , 10 % H 2 and 10 % CO 2 , and bacterial growth was monitored by determining optical density at 600 nm (OD 600 ). The lowest concentration of CR that inhibited bacterial growth was selected as the MIC, and the two highest CR concentrations below the MIC that did not inhibit bacterial growth after 24 h of incubation were selected as the SICs for this study.
Effect of CR on C. difficile growth and sporulation
The effect of CR on C. difficile growth and sporulation was determined according to a previously published protocol [24] . Briefly, BHI with or without the SICs of CR was inoculated (5 log c.f.u. ml À1 ) separately with each C. difficile isolate, and incubated at 37
C for 96 h anaerobically as before. Samples were withdrawn at different time intervals (24, 48, 72 and 96 h) for quantification of heat-resistant spores (survivors of incubation at 60 C for 20 min) and total viable count (TVC) by serially diluting each sample in PBS and plating on BHIS agar supplemented with 0.1 % taurocholate. In addition, sporulation in BHIS at the specified time intervals was visualized under phase-contrast microscopy [25] . A 10 µl aliquot of the culture from different treatment groups was loaded onto a microscopy slide, air-dried and visualized under 1.5Â40 magnification.
Effect of SIC and MIC of CR on C. difficile spore germination and outgrowth To study the effect of CR on C. difficile spore germination, 100 µl suspension containing 10 5 spores ml À1 was added to the wells of a 12-well plate containing 1.9 ml of pre-warmed, pre-reduced BHI supplemented with 0.1 % sodium taurocholate (Sigma-Aldrich, St Louis, MO, USA) inside an anaerobic workstation. The plates were closed inside the workstation with lids and sealed with a sealant. Brain-heart infusion without taurocholate and spore suspensions or medium replaced with distilled water were included as controls. A well with resazurin 0.1 mg ml À1 was included for monitoring anaerobiosis in the plates during reading. Optical density at 600 nm was recorded using a Synergy plate reader (Biotek, Winooski, VT, USA) at 37 C over a 24 h time period, with readings taken at 10 min intervals, and was expressed as a percentage of the initial OD 600 (t/t 0 ). Spore germination was measured as the initial loss of OD 600 and spore outgrowth was measured by recording the increase in OD 600 following spore germination, as described previously [26, 27] .
Real-time quantitative PCR (RT-qPCR)
To determine the effect of CR on the C. difficile genes involved in spore production, total RNA was isolated from early stationary-phase cultures grown with and without the SIC of CR [28] . The culture supernatant was harvested by centrifugation at 3000 g for 10 min at 4 C. The bacterial pellet was resuspended in RNAwiz solution (Ambion, Austin, TX, USA), flash frozen in liquid nitrogen and stored at À80 C. Total RNA extraction was performed using the Ambion RiboPure Bacteria RNA kit according to the manufacturer's instructions, followed by DNase I digestion using Turbo DNase I (Ambion, Austin, TX, USA). The RNA obtained after each DNase I digestion was purified further using the Qiagen RNeasy RNA column purification kit (Qiagen, Germantown, MD, USA). The cDNA was synthesized using the Bio-Rad iScript cDNA synthesis kit (BioRad, Hercules, CA, USA). RT-qPCR analysis was performed using published primers for genes associated with sporulation (Spo0A, SpoIIA, SpoIIID, SpoIIR, SigH and Cd2492) [12, 24] and normalized against 16S rRNA gene expression. The level of candidate gene expression between treated and control samples was determined using the 2 ÀDDCT method and expressed as relative fold change [29] .
Statistical analysis
All experiments had duplicate samples, and the study was repeated three times. The data were analysed using one-way ANOVA. Differences between means were considered to be significant at P<0.05.
RESULTS
Effect of CR on C. difficile growth and sporulation The MIC of CR against C. difficile was 1.2 mM. The two highest SICs of CR were found to be 0.9 mM and 0.6 mM. These two concentrations of CR did not inhibit the growth of C. difficile isolates after 24 h incubation at 37 C. The effect of SICs of CR on C. difficile spore production is shown in (Fig. 1a, b) . In both C. difficile isolates, a significant decrease in spore counts was observed after 48 and 72 h of incubation in CR-treated samples compared to control (P<0.05). In C. difficile BAA 1870, CR at 0.6 mM and 0.9 mM resulted in~1.5 log c.f.u. ml À1 and 2.0 log c.f.u. ml À1 reduction in spore counts at 48 and 72 h of incubation, respectively. At 96 h, although spore counts in 0.6 mM CRtreated samples grew back by~1.0 log c.f.u. ml
À1
, CR treatment at 0.9 mM reduced the spore count~3 log c.f.u. ml À1 (Fig. 1a) . However, the differences in total viable counts (plated without heat treatment) between CR-treated samples and untreated control were minimal (P>0.05). Similar results were also observed in C. difficile BAA 1805 (Fig. 1b) , where~1 log c.f.u. ml À1 reduction in spore count was observed in 0.6 mM CR-treated cultures at 48, 72 and 96 h. Similarly, in the presence of 0.9 mM CR, a 2 log reduction in spore counts was observed consistently from 48 h through 96 h. Moreover, the differences in total viable counts between CR-treated and control samples were less than 1.0 log c.f.u. ml À1 throughout the sampling times (P>0.05). The results from the spoulation experiments were consistent with the phase-contrast microscopy results for CR-treated and untreated C. difficile cultures (Fig. 2) . In the untreated control, more phase-bright spores and fewer vegetative bacteria populations were observed throughout the microscopic field. Conversely, in CR-treated C. difficile culture, more vegetative bacteria, fewer phase-bright spores and a few phase-dark spores were observed after 48 h of incubation.
Effect of CR on C. difficile spore germination and outgrowth The effect of SIC (0.6 mM) and MIC (1.2 mM) of CR on C. difficile spore germination and outgrowth over a 24 h time period was determined. In C. difficile BAA 1870, spore outgrowth was observed in untreated wells, as indicated by an increase in OD 600 starting at 11 h, with continued increase over the 24 h duration (Fig. 3a) . However, in the presence of 0.6 mM CR, C. difficile spore outgrowth was delayed, as indicated by a lower absorbance at each sampling time point (P<0.05). In addition, the MIC of CR (1.2 mM) completely inhibited spore outgrowth, as is evident from a lack of increase in absorbance at 600 nm. In C. difficile BAA 1805, CR was found to be more effective, and at 0.6 mM spore outgrowth was delayed by 3 h, while growth was found to be decreased throughout the sampling points (P>0.05) (Fig. 3b) . Moreover, CR at 1.2 mM completely shut down spore outgrowth, as observed with C. difficile BAA 1870. No significant difference was observed in the initial dip in the OD 600 in both CR-treated (SIC and MIC) and untreated C. difficile, indicating that neither SIC nor MIC of CR was able to reduce C. difficile spore germination.
Effect of CR on C. difficile spore-production genes To investigate whether the observed reduction in C. difficile spore production was due to a modulation in the expression of genes known to be involved in sporulation, RT-qPCR was performed. The results showed that CR significantly down-regulated the transcription of C. difficile sporulation genes, where the expression of spo0A was down-regulated by 22-fold in BAA 1870 and 13-fold in BAA 1805, and that of spoIIA was down-regulated by 23-fold and 25-fold in BAA 1870 and BAA 1805, respectively (Table 1 ). In addition, the transcription of spoIIR was decreased by seven-fold and eight-fold, and that of spoIIID by five-fold and sevenfold, in C. difficile BAA 1870 and 1805, respectively (P<0.05). Similarly, sigH was down-regulated by 19-fold and 26-fold in C. difficile BAA 1870 and BAA 1805, respectively (P<0.05). Likewise, the expression of CD2492 was also reduced by 14-fold and sevenfold in C. difficile BAA 1870 and BAA 1805 isolates, respectively (P<0.05).
DISCUSSION
The results from this study suggest that CR, a plant-derived, food-grade compound that has previously been shown to exert an anti-toxigenic effect in C. difficile can significantly reduce C. difficile spore production and spore outgrowth in vitro. The SICs of CR significantly reduced spore production by C. difficile at 48, 72 and 96 h of incubation (P<0.05).
The reduction in sporulation in CR-treated samples was determined by the dilution and plating method, and also visualized using phase-contrast microscopy. Interestingly, no reduction in the total number of viable cells was observed in CR-treated C. difficile cultures compared to the untreated control. These results indicate that CR was able to specifically inhibit the formation of spores from the vegetative cells in broth culture. A slight increase in the TVC of CR-treated cultures could be due to the presence of a higher proportion of vegetative cells, which have a superior detection limit on plating compared to spores [30] . Since the SICs of CR were used in the sporulation experiments, the decrease observed in C. difficile spore production in CRtreated samples was not due to inhibition of bacterial growth by CR, but it could be attributed to their potential ability to reduce the transcription of virulence genes associated with spore production. In concurrence with this, the gene expression studies indicated that CR significantly down-regulated critical genes responsible for C. difficile sporulation. In the germination experiments, the results revealed that the SIC of CR (0.6 mM) significantly reduced C. difficile spore outgrowth (outgrowth of vegetative cells from the newly germinated spores) compared to the controls (P<0.05), whereas CR at the MIC (1.2 mM) completely inhibited the spore outgrowth. These results suggest that vegetative cells from newly germinated spores are more sensitive to CR compared to vegetative C. difficile cells grown in broth.
A potential alternative strategy for controlling microbial infections is the use of anti-virulence drugs, which target the reduction of bacterial virulence rather than the inhibition of bacterial growth [31] , thereby presenting less selective pressure for the development of bacterial antimicrobial resistance [32] [33] [34] . The results of the current study indicate that CR inhibited sporulation in C. difficile, which aids in bacterial virulence, especially towards CDI transmission and relapse. Moreover, prior research conducted in our laboratory revealed that the SICs of CR inhibited the production of C. difficile toxins, which represent another important virulence factor in the pathogen, without inhibiting the normal gut bacteria [21] . Other researchers also reported that CR exerted no adverse effects on endogenous bacterial populations, including Lactobacilli and Bifidobacteria in pigs and poultry [35] . To conclude, the results from this study suggest the potential of CR for controlling C. difficile by reducing spore production and outgrowth, thereby warranting follow-up in vivo studies to confirm the findings. A spore suspension containing 10 5 spores/ml was added to pre-reduced BHI supplemented with 0.1 % sodium taurocholate and incubated with 0 mM, 6 mM or 12 mM CR inside an anaerobic workstation. Optical density at 600 nm (OD 600 ) was recorded and is expressed as a percentage of the initial OD 600 (t/t 0 ). Germination was measured as the initial loss of OD 600 and spore outgrowth was measured by recording the increase in OD600 following spore germination. Error bar indicates SE. Funding information
